Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 19617 NEW YORK, NY
Back to ZVRA Full portfolio

Position in ZVRA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$5,175,663
+$1,644,018 QoQ
Shares Held
360,925
-4.8% QoQ
Ownership
0.608%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 158 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 86% Shared 0% None 14%

Common Shares in ZVRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. ZVRA ranks #112 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in ZVRA

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,175,663 360,925
2026-03-31 $3,531,645 378,932
2025-12-31 $3,693,857 412,261
2025-09-30 $4,174,736 438,984
2025-06-30 $248,097 28,161
2025-03-31 $218,242 29,138
2024-12-31 $229,265 27,490
2024-09-30 $126,759 18,265
2024-06-30 $91,457 18,665
2024-03-31 $87,352 15,061
2023-12-31 $176,154 26,894
2023-09-30 $112,126 23,263
2023-06-30 $141,136 27,674
2023-03-31 $4,279 778
2022-12-31 $4 778
2022-09-30 $13,572 2,175
2022-06-30 $6,966 1,562
2022-03-31 $91,017 18,095
2021-12-31 $122,854 14,105
2021-09-30 $138,708 14,867
2021-06-30 $140,661 10,972